drugset / Trial / NCT00035191
A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a trial to evaluate the safety and effectiveness of galantamine in patients with dementia secondary to blood vessel disease in the brain.
Timeline
- Start
- 2001-10
- Primary completion
- —
- Completion
- 2003-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Galantamine | Small molecule | 8 mg | — |
| Subject | Galantamine | Small molecule | 12 mg | — |